Latest Headlines

  1. Epredia And Mindpeak Announce EU Distribution Agreement For AI-Powered Image Recognition In Cancer Diagnostics 2/24/2026

    Epredia, a global leader in precision cancer diagnostics and a subsidiary of PHC Holdings Corporation and Mindpeak, a leading provider of artificial intelligence (AI) solutions for clinical and research pathology, today announced a distribution agreement to bring Mindpeak’s AI-based image recognition software to Epredia’s digital pathology customers in the European Union.

  2. Rapid And Accurate Method From VTT For Detecting Hormones, Toxins And Other Small Molecules 2/24/2026

    In the field of diagnostics, there has long been a search for solutions to measure low concentrations of small molecules accurately, quickly and easily, for example from food, the environment or a patient sample.

  3. ClearNote Health's Enhanced Avantect Pancreatic Cancer Test Delivers Industry-Leading Early Detection Performance 2/23/2026

    ClearNote Health, a company focused on improving early detection for some of the deadliest cancers, today announced the availability of its enhanced Avantect Pancreatic Cancer Test, which delivers significantly improved detection for patients at elevated risk of this disease.

  4. BD Expands Testing Capabilities To Help Clinicians Improve Diagnostic Accuracy And Efficiency 2/23/2026

    BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of the BD Vacutainer® Urine Complete Cup Kit, a three-tube collection system that expands and supports broader testing capabilities from a single urine specimen.

  5. Volta Labs And Watchmaker Genomics Partner To Introduce Callisto™ Complete Kit For DNA EF Library Prep At AGBT 2026 2/23/2026

    At the Advances in Genome Biology and Technology (AGBT) General Meeting 2026 in Orlando, FL, Volta Labs, a leader in next-generation sequencing (NGS) sample preparation automation, today announced the launch of the Callisto™ Complete Kit for DNA EF Library Prep.

  6. Labcorp Expands Collaboration With PathAI To Deploy FDA-Cleared Digital Pathology Platform Nationwide 2/23/2026

    Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced an expanded collaboration with PathAI to deploy AISight® Dx1, an FDA-cleared digital pathology platform, across its national network of anatomic pathology labs and hospital collaborations.

  7. Parse Biosciences Launches Evercode Whole Transcriptome V4 With Shorter Workflow, Higher Sensitivity And Higher Cell Recovery 2/19/2026

    Parse Biosciences, a QIAGEN company and the leading provider of scalable and accessible single-cell sequencing solutions today announced the launch of the new Evercode Whole Transcriptome v4 product line, delivering expanded scalability, higher sensitivity and a simplified workflow for single-cell RNA sequencing.

  8. DEXIS Advances Digital Dentistry With Enhanced Lab-To-Clinic Workflow Solutions 2/19/2026

    DEXIS™, a global leader in digital diagnostic imaging and intraoral scanning solutions, today announced significant advancements to its lab-to-clinic workflow solutions during a week of key industry events in Chicago—including LMT Lab Day and Chicago Midwinter Meeting—reinforcing its focus on setting the standard for digital collaboration across dentistry.

  9. Breath Diagnostics, Inc. Receives FDA Breakthrough Device Designation For OneBreath™ Platform To Aid Pre-Operative Pneumonia Risk Assessment 2/19/2026

    Breath Diagnostics, Inc., a leader in breath-based molecular diagnostics powered by patented microreactor capture technology, is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to its OneBreath™ platform.

  10. Meridian Life Science Expands Ambient-Stable NGS Portfolio With The Launch Of A Lyophilized Enzymatic DNA Fragmentation Kit 2/18/2026

    The Life Science division of Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, today announced the launch of its Lyophilized NGS Enzymatic DNA Fragmentation Kit.